280 related articles for article (PubMed ID: 16858953)
21. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
Burke JP; Sander S; Shah H; Zarotsky V; Henk H
Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138
[TBL] [Abstract][Full Text] [Related]
22. The approach to optimizing stroke care.
Panagos PD
Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
[TBL] [Abstract][Full Text] [Related]
23. Antithrombotic drugs for prevention of recurrent stroke.
Pettigrew LC; Williams SC
J Ky Med Assoc; 2002 May; 100(5):184-93. PubMed ID: 12040909
[TBL] [Abstract][Full Text] [Related]
24. Low- versus high-dose aspirin in prevention of ischemic stroke.
Adams HP; Bendixen BH
Clin Neuropharmacol; 1993 Dec; 16(6):485-500. PubMed ID: 9377584
[TBL] [Abstract][Full Text] [Related]
25. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
[TBL] [Abstract][Full Text] [Related]
26. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
[TBL] [Abstract][Full Text] [Related]
27. Titrated initiation of acetylsalicylic acid-dipyridamole therapy reduces adverse effects and improves tolerance in patients with stroke.
Douen AG; Medic S; Sabih M; Pageau N; Shuaib A
J Stroke Cerebrovasc Dis; 2008; 17(6):356-9. PubMed ID: 18984426
[TBL] [Abstract][Full Text] [Related]
28. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
Bhatt DL; Flather MD; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Fabry-Ribaudo L; Hu T; Topol EJ; Fox KA;
J Am Coll Cardiol; 2007 May; 49(19):1982-8. PubMed ID: 17498584
[TBL] [Abstract][Full Text] [Related]
29. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
Sztriha LK; Vécsei L
Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
[TBL] [Abstract][Full Text] [Related]
30. The European Stroke Prevention Study (ESPS): results by arterial distribution.
Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
[TBL] [Abstract][Full Text] [Related]
31. Dipyridamole plus aspirin: the best regimen for stroke prevention after noncardioembolic focal cerebral ischemia.
Jonas S; Grieco G
Cerebrovasc Dis; 2006; 22(1):1-3. PubMed ID: 16567930
[No Abstract] [Full Text] [Related]
32. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy.
Khajehdehi P; Roozbeh J; Mostafavi H
Scand J Urol Nephrol; 2002; 36(2):145-8. PubMed ID: 12028688
[TBL] [Abstract][Full Text] [Related]
33. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
Zhao L; Gray L; Leonardi-Bee J; Weaver CS; Heptinstall S; Bath PM
Platelets; 2006 Mar; 17(2):100-4. PubMed ID: 16421011
[TBL] [Abstract][Full Text] [Related]
34. [Transient ischemic attacks and prolonged reversible ischemic neurologic deficit. Diagnosis, differential diagnosis and treatment].
Mosso M; Baumgartner RW
Praxis (Bern 1994); 2000 Mar; 89(13):542-8. PubMed ID: 10776056
[TBL] [Abstract][Full Text] [Related]
35. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
Diener HC
MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
[No Abstract] [Full Text] [Related]
36. Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke.
Sarma GR; Roy AK
Neurol India; 2003 Jun; 51(2):208-10. PubMed ID: 14571005
[TBL] [Abstract][Full Text] [Related]
37. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
Thijs V; Lemmens R; Fieuws S
Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
[TBL] [Abstract][Full Text] [Related]
38. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
[TBL] [Abstract][Full Text] [Related]
39. [Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].
Gorter JW; De Schryver EL; Algra A
Ned Tijdschr Geneeskd; 1998 Feb; 142(6):316-8. PubMed ID: 9562733
[TBL] [Abstract][Full Text] [Related]
40. Prevention of recurrent ischemic stroke.
Dickerson LM; Carek PJ; Quattlebaum RG
Am Fam Physician; 2007 Aug; 76(3):382-8. PubMed ID: 17708138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
